West Orange, N.J.-based RWJBarnabas Health and the Rutgers Cancer Institute of New Jersey will break ground on a $750 million cancer facility June 24. 

Of 423 encounters between oncologists and patients, just 5 percent included end-of-life discussions, with oncologists often shying away from such conversations even when the opportunity presented itself, according to findings recently published in JAMA Network Open.

For patients with high-grade serous ovarian cancer, an aggressive form of the disease, surgery to remove the tumor before starting chemotherapy should lead to better outcomes than the reverse, according to research published June 14 in Proceedings of the National Academy of Sciences.

An urgent care center dedicated to cancer patients is slated to open in late fall at Saint Francis Hospital —  Memphis (Tenn.), The Commercial Appeal reported June 15.

U.S. News & World Report released its 2021-22 Best Children's Hospitals ranking for cancer care June 15, with Children's Hospital of Philadelphia taking the top spot.

New York City-based Mount Sinai Health System has tapped Joseph Sparano, MD, as chief of hematology and medical oncology.

A small survey shows oncologists may often underestimate their patients' use of complementary medicines, Medscape reported June 14. 

Edward Kim, MD, PhD, will serve as the medical director of clinical research at UC Davis Comprehensive Cancer Center in Sacramento, Calif., effective July 1. 

Nearly a quarter of childhood cancer survivors experience at least one debilitating neuromuscular condition 20 years post diagnosis, according to a study published in the June issue of Cancer, Epidemiology, Biomarkers & Prevention. 

These four oncologists joined new practices or received new appointments over the last few months. 

Here are four hospitals, health systems and cancer institutes that have expanded their facilities or shared plans to open new centers since May 25. 

While current U.S. guidelines recommend cervical cancer screening stop at age 65, less than 1 in 3 women aged 64-66 met the criteria to safely discontinue screening, according to research published June 7 in Gynecologic Oncology.

Here are four recent cancer care and research-related partnerships and affiliations formed since May 11. 

Throughout the past year, 70 percent of oncologists surveyed reported some form of sexual harassment by their peers or superiors, according to findings recently published in the Journal of Clinical Oncology.

AstraZeneca's Lynparza drug cut the combined risk of recurrence of cancer or death from any cause by 42 percent among early-stage breast cancer patients with certain mutations, compared to those who received a placebo, according to research published June 3 in The New England Journal of Medicine. 

The Sidney Kimmel Cancer Center in Philadelphia, part of Jefferson Health, has named Andrew Aplin, PhD, as deputy director of scientific strategy.

The National Cancer Institute removed Axel Grothey, MD, from his position as co-chair of a steering committee May 27 after reports surfaced that the physician had inappropriate sexual relationships with mentees while working at Rochester, Minn.-based Mayo Clinic, Medscape reported June 1. 

In an era of infinite challenges and finite resources, health systems must employ a rigorous approach to strategic and facility planning. This is particularly true for oncology, where the pace of change and innovation is unprecedented.

An odor-based test developed by researchers at the University of Pennsylvania's medical school in Philadelphia identified cancer cells with up to 95 percent accuracy, according to findings set to be presented June 4 at the 2021 American Society of Clinical Oncology annual meeting. 

Biosimilars are FDA-approved medicines that are rigorously tested and subject to the same quality manufacturing standards as reference medicines.